Shenzhen Salubris Pharmaceuticals Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2024: USD -208.94 M

Shenzhen Salubris Pharmaceuticals Co., Ltd. Net Cash Used For Investing Activities is USD -208.94 M for the year ending December 31, 2024, a 5.87% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Shenzhen Salubris Pharmaceuticals Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2023 was USD -197.35 M, a 6.96% change year over year.
  • Shenzhen Salubris Pharmaceuticals Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -184.52 M, a 217.17% change year over year.
  • Shenzhen Salubris Pharmaceuticals Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -58.18 M, a -55.30% change year over year.
  • Shenzhen Salubris Pharmaceuticals Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -130.13 M, a 326.85% change year over year.
Key Data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Depreciation And Amortization Dividends Paid